Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder

Psychiatric Quarterly

Volumn 75, Issue 4, 2004, Pages 309-320

  Phillips, Katharine A ^a   Siniscalchi, Jason M ^a   McElroy, Susan L ^b  

^a BUTLER HOSPITAL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anxiety; Body dysmorphic disorder; Depression; Hostility; Somatic symptoms

Indexed keywords

FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANGER; ANXIETY; ARTICLE; BODY DYSMORPHIC DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISTRESS SYNDROME; FEMALE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PSYCHOSOMATIC DISORDER; QUESTIONNAIRE; SAMPLE SIZE; SCORING SYSTEM; SOMATIZATION; VALIDATION PROCESS; WELLBEING; DRUG EFFECT; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SOMATOFORM DISORDER; UNITED STATES;

ADULT; ANGER; ANXIETY; DEPRESSION; FEMALE; FLUVOXAMINE; HUMANS; MALE; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SOMATOFORM DISORDERS; UNITED STATES;

EID: 16644362193     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1023/B:PSAQ.0000043507.03596.0d     Document Type: Article

References (30)

1. Phillips KA, McElroy SL, Keck PE, Jr, et al: Body dysmorphic disorder: 30 cases of imagined ugliness. American Journal of Psychiatry 150:302-308, 1993.
2. Perugi G, Giannotti D, Frare F, et al: Prevalence, phenomenology, and comorbidity of body dysmorphic disorder (dysmorphophobia) in a clinical population. International Journal of Psychiatry and Clinical Practice 1:77-82, 1997.
3. Grant JE, Kim SW, Crow SJ: Prevalence and clinical features of body dysmorphic disorder in adolescent and adult psychiatric inpatients. Journal of Clinical Psychiatry 62:517-522, 2001.
4. Bienvenu OJ, Samuels JF, Riddle MA, et al: The relationship of obsessive-compulsive disorder to possible spectrum disorders: Results from a family study. Biological Psychiatry 48:287-293, 2000.
5. Phillips KA: Quality of life for patients with body dysmorphic disorder. Journal of Nervous and Mental Disease 188:170-175, 2000.
6. Veale D, Boocock A, Gournay K, et al: Body dysmorphic disorder: A survey of fifty cases. British Journal of Psychiatry 169:196-201, 1996.
7. Phillips KA, Albertini RS, Rasmussen SA: A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Archives of General Psychiatry 59:381-388, 2002.
8. Phillips KA, Dwight MM, McElroy SL: Efficacy and safety of fluvoxamine in body dysmorphic disorder. Journal of Clinical Psychiatry 59:165-171, 1998.
9. Saxena S, Winograd A, Dunkin JJ: A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive compulsive disorder. Journal of Clinical Psychiatry 62:67-72, 2001.
10. Perugi G, Giannotti D, Di Vaio F, et al: Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). International Clinical Psychopharmacology 11:247-254, 1996.
11. DeMarco L, Li L, Phillips KA, McElroy S: Perceived stress in body dysmorphic disorder. Journal of Nervous and Mental Disease 186:724-726, 1998.
12. Kellner R: A symptom questionnaire. Journal of Clinical Psychiatry 8:268-274, 1987.
13. Lucas P: Violence may be serious in men with body dysmorphic disorder (letter). British Medical Journal 324:678, 2002.
14. Phillips KA, McElroy SL, Lion JR: Body dysmorphic disorder in cosmetic surgery patients (letter). Plastic and Reconstructive Surgery 90:333-334, 1992.
15. Phillips KA, Nierenberg AA, Brendel G: Prevalence and clinical features of body dysmorphic disorder in atypical major depression. Journal of Nervous and Mental Disease 184:125-129, 1996.
16. Phillips KA, McElroy SL: Personality disorders and traits in patients with body dysmorphic disorder. Comprehensive Psychiatry 41:229-236, 2000.
17. Fava M, Rosenbaum JF, Pava JA, et al: Anger attacks in unipolar depression, part 1: Clinical correlates and response to fluoxetine treatment. American Journal of Psychiatry 150:1158-1163, 1993.
18. Phillips KA, McElroy SL, Keck PE, Jr, et al: A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacology Bulletin 30:179-186, 1994.
19. Phillips KA, Hollander E, Rasmussen SA, et al: A severity rating scale for body dysmorphic disorder: Development, reliability, and validity of a modified version of the Yale-Brown Obsessive-Compulsive Scale. Psychopharmacology Bulletin 33:17-22, 1997.
20. Kellner R, Abbott P, Pathak D, et al: Hypochondriacal beliefs and attitudes in family practice and psychiatric patients. International Journal of Psychiatry and Medicine 13:127-139, 1983/84.
21. Spitzer RL, Williams JBW, Gibbon M, et al: The Structured Clinical Interview for DSM-III-R (SCID): I. History, rationale, and description. Archives of General Psychiatry 49:624-629, 1992.
22. Phillips KA, Atala KD, Pope HG: Diagnostic instruments for body dysmorphic disorder, in New Research Program and Abstracts, American Psychiatric Association 148th Annual Meeting. Miami, FL: American Psychiatric Association, 1995, p. 157.
23. Phillips KA, McElroy SL, Dwight MM, et al: Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. Journal of Clinical Psychiatry 62:87-91, 2001.
24. Gunstad J, Phillips KA: Axis I comorbidity in body dysmorphic disorder. Comprehensive Psychiatry 44:270-276, 2003.
25. Hollander E: Introduction, in Obsessive-Compulsive Related Disorders. Edited by Hollander E. Washington, DC, American Psychiatric Press, 1993.
26. Cohen LJ, Stein DJ, Simeon D, et al: Obsessive-compulsive spectrum disorders, in Obsessive-Compulsive Disorders. Edited by Hollander E, Stein DJ. New York, Marcel Dekker, 1997, pp. 47-74.
27. Fava GA, Kellner R, Lisansky J, et al: Hostility and recovery from melancholia. Journal of Nervous and Mental Disease 174:414-417, 1986.
28. Fava M, Davidson K, Alpert JE, et al: Hostility changes following antidepressant treatment: Relationship to stress and negative thinking. Journal of Psychiatric Research 30:459-467, 1996.
29. Coccaro EF, Kavoussi RJ: Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry 54:1081-1088, 1997.
30. Lee R, Coccaro E: The neuropsychopharmacology of criminality and aggression. Canadian Journal of Psychiatry 46:35-44, 2001.